KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $82.4 million.

  • Encompass Health's Depreciation & Amortization (CF) rose 510.2% to $82.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $319.5 million, marking a year-over-year increase of 953.03%. This contributed to the annual value of $299.6 million for FY2024, which is 938.3% up from last year.
  • According to the latest figures from Q3 2025, Encompass Health's Depreciation & Amortization (CF) is $82.4 million, which was up 510.2% from $79.9 million recorded in Q2 2025.
  • Over the past 5 years, Encompass Health's Depreciation & Amortization (CF) peaked at $82.4 million during Q3 2025, and registered a low of $55.5 million during Q3 2021.
  • For the 5-year period, Encompass Health's Depreciation & Amortization (CF) averaged around $68.2 million, with its median value being $67.3 million (2023).
  • Examining YoY changes over the last 5 years, Encompass Health's Depreciation & Amortization (CF) showed a top increase of 15426.01% in 2021 and a maximum decrease of 931.37% in 2021.
  • Quarter analysis of 5 years shows Encompass Health's Depreciation & Amortization (CF) stood at $56.7 million in 2021, then grew by 11.64% to $63.3 million in 2022, then rose by 10.74% to $70.1 million in 2023, then increased by 11.27% to $78.0 million in 2024, then increased by 5.64% to $82.4 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $82.4 million for Q3 2025, versus $79.9 million for Q2 2025 and $79.2 million for Q1 2025.